MEDA Ventures is a US healthcare venture capital group investing in

privately-held US and foreign-based companies in therapeutics, medical

devices and digital health. We are a physician- and scientist-founded group

targeting high impact opportunities.

Developer of an innovative clinical trial insurance and funding vehicle: For investments in therapeutics companies, MEDA Partners have developed a highly unique clinical trial insurance and funding vehicle

launched by Lloyd’s of London together with equity and debt investors. The

new Lloyd insurance pays investors back their capital in case the

endpoints in a trial are not met and is being used to enable secured equity

and debt investments into trials. MEDA Ventures will potentially invest

alongside this vehicle capitalizing on the extensive underwriting performed

for Lloyd's insurance coverage through the use of an AI predictive platform through of GATC Health.